BioVaxys Reports Positive Clinical Study Results from Phase 1B/2 PESCO Trial of MVP-S with Pembrolizumab ) and Low-Dose Cyclophosphamide for Patients with Recurrent Epithelial Ovarian Cancer Life Science Investing
Dyne Therapeutics Receives Orphan Drug Designation in Japan for Zeleciment Basivarsen for Myotonic Dystrophy Type 1 Life Science Investing
Harbour BioMed Acquires Common Stock in Spruce Biosciences, Deepening Strategic Collaboration Life Science Investing
Tiziana Life Sciences Announces Closing of Oversubscribed $8.8 Million Registered Direct Offering of Ordinary Shares Life Science Investing
Doseology Files Annual Information Form , Strengthening Public Disclosure Record AIF Filing Enhances Transparency and Provides Consolidated Disclosure for Investors Life Science Investing
Doseology Files Annual Information Form , Strengthening Public Disclosure Record AIF Filing Enhances Transparency and Provides Consolidated Disclosure for Investors Life Science Investing
Cardiol Therapeutics Announces Bought Deal Financing for Gross Proceeds of $13.5 Million Biotech Investing
Cardiol Therapeutics Inc. Announces Bought Deal Financing for Gross Proceeds of $13.5 Million Biotech Investing
